Search Results

Drug pricing reform and a thorough analysis of healthcare spending have been the focus of healthcare leadership across the country since early 2018.

In 2016, we saw the Obama Administration finalize regulations around sweeping physician payment reform in Medicare, oncology practices nationwide navigate the first year of the Oncology Care Model (OCM), policymakers try—and fail—to push through drug pricing reform with a national mandatory demonstration program, the 21st Century Cures Act signed into law, and the drug pricing debate hit a fever …